S510-0315 Screening compound: 3-{3-[1-(3-methoxybenzoyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-5-yl}-1-(4-methylpiperazin-1-yl)propan-1-one

S510-0315 Screening compound: 3-{3-[1-(3-methoxybenzoyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-5-yl}-1-(4-methylpiperazin-1-yl)propan-1-one
S510-0315 Screening compound: 3-{3-[1-(3-methoxybenzoyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-5-yl}-1-(4-methylpiperazin-1-yl)propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S510-0315
3-{3-[1-(3-methoxybenzoyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-5-yl}-1-(4-methylpiperazin-1-yl)propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S510-0315

Molecular Formula

C22H29N5O4 (C22 H29 N5 O4)

Compound Name

3-{3-[1-(3-methoxybenzoyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-5-yl}-1-(4-methylpiperazin-1-yl)propan-1-one

IUPAC name

3-{3-[1-(3-methoxybenzoyl)pyrrolidin-2-yl]-124-oxadiazol-5-yl}-1-(4-methylpiperazin-1-yl)propan-1-one

SMILES

CN(CC1)CCN1C(CCc1nc(C(CCC2)N2C(c2cc(OC)ccc2)=O)no1)=O

InChI

InChI=1S/C22H29N5O4/c1-25-11-13-26(14-12-25)20(28)9-8-19-23-21(24-31-19)18-7-4-10-27(18)22(29)16-5-3-6-17(15-16)30-2/h3,5-6,15,18H,4,7-14H2,1-2H3/t18-/m0/s1

InChI Key

QRVVJGJABFOSPR-SFHVURJKSA-N

MDL Number (MFCD)

MFCD31981374

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

427.5

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.079

Distribution Coefficient, logD

0.832

Water Solubility, LogSw

-1.90

Polar Surface Area

75.431

Acid Dissociation Constant (pKa)

23.79

Base Dissociation Constant (pKb)

7.28

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

54.54

S510-0315 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with S510-0315 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S510-0315?
Check Price and Availability of S510-0315, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S510-0315 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S510-0315
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S510-0315
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S510-0315 available by request